Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial
JAMA Oncol 2020 Jul 30;[EPub Ahead of Print], O Klein, D Kee, A Nagrial, B Markman, C Underhill, M Michael, L Jackett, C Lum, A Behren, J Palmer, NC Tebbutt, MS Carlino, J CebonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.